Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Professor Amnon Shashua and Karl Iagnemma are riding the wave of exits in the self-driving space

Shashua and Iagnemma are No. 41 on the Recode 100.

Professor Amnon Shashua and Karl Iagnemma are riding the wave of exits in the self-driving space

Shashua and Iagnemma are No. 41 on the Recode 100.

No one company dominates the self-driving industry. That means there’s room for smaller players to play a bigger hand in the next big thing.

And that’s why nuTonomy, a self-driving startup developing the brains of a driverless car, co-founded by Karl Iagnemma, and Mobileye, a supplier that develops the software for the sensors or the eyes of an autonomous vehicle, co-founded by Professor Amnon Shashua, made significant exits this year.

Automotive supplier Delphi bought nuTonomy for $450 million in October while Mobileye sold to Intel for a whopping $15 billion, making it Israel’s largest tech exit ever. Both acquisitions give the companies the resources and scale of an established company and the independence to service the wider auto industry.

Under Iagnemma, nuTonomy has launched self-driving pilots in Boston and Singapore and struck partnerships with companies like Lyft. Most recently, Shashua proffered one of the first mathematical models for safety standards for autonomous vehicles.

This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh